We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EL market cap is 92.9B. The company's latest EPS is EUR 5.0437 and P/E is 43.54.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 17.39B | 14.43B | 19.82B | 24.49B | 25.4B |
| Operating Income | 1.65B | 459M | 2.31B | 3.16B | 3.18B |
| Net Income | 1.08B | 85M | 1.45B | 2.15B | 2.29B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 52.58B | 52.32B | 59.42B | 60.56B | 60.52B |
| Total Liabilities | 17.25B | 19.52B | 23.54B | 22.41B | 21.63B |
| Total Equity | 35.33B | 32.8B | 35.88B | 38.15B | 38.89B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 3.3B | 2.95B | 4.55B | 4.78B | 4.86B |
| Investing | -1.69B | -480M | -8.06B | -2.62B | -1.72B |
| Financing | 1.38B | 1.5B | -2.04B | -3.58B | -2.43B |
| Market Cap | 92.9B |
| Price to Earnings Ratio | 43.54 |
| Price to Sales Ratio | 3.92 |
| Price to Cash Ratio | 38.96 |
| Price to Book Ratio | 2.56 |
| Dividend Yield | 1.58% |
| Shares Outstanding | 453.83M |
| Average Volume (1 week) | 441.88k |
| Average Volume (1 Month) | 441.75k |
| 52 Week Change | 10.33% |
| 52 Week High | 212.40 |
| 52 Week Low | 159.68 |
| Spread (Intraday) | 2.2 (1.07%) |
| Company Name | Essilorluxottica |
| Address |
147 rue de paris charenton-le-pont, val-de-marne 94220 |
| Website | https://www.essilorluxottica.com |
| Industry | ophthalmic goods (3851) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
